Related Experiment Video
Updated: Aug 18, 2026

Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches--augmentation of
M Shimohata1, T Shimohata, S Igarashi
1Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan. m-shimohata@pop17.odn.ne.jp
Abstract:
On the basis of the hypothesis that the interaction of mutant proteins with expanded polyglutamine stretches with transcriptional co-activator, TAFII130, leads to transcriptional dysregulation, the transcriptional activation of c-Fos and its suppression by expanded polyglutamine stretches was investigated. The phosphorylation of cAMP-responsive element binding protein (CREB) and induction of c-Fos in response to cAMP were strongly suppressed in Neuro2a cells expressing expanded polyglutamine. The suppression of CREB-dependent transcriptional activation was reversibly rescued by increasing the concentration of cAMP. Expanded polyglutamine-induced cytotoxicity was also substantially suppressed by augmenting CREB-dependent transcriptional activation with a high concentration of cAMP. FR901228, a histone deacetylase inhibitor, was also demonstrated as rescuing the expanded polyglutamine-induced suppression of CREB phosphorylation and c-Fos expression. Furthermore, nuclear fragmentation was significantly suppressed by FR901228. The co-expression of dominant-negative CREB vectors considerably abrogated the suppressive effect of cAMP and FR901228 on the expanded polyglutamine-induced nuclear fragmentation, suggesting that these compounds suppress polyglutamine-induced cytotoxicity, largely, via the enhancement of CREB-dependent transcriptional activation. These findings suggest that the interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches is involved in the pathogenetic mechanisms underlying neurodegeneration, and that the augmentation of CREB-dependent transcriptional activation is a potential strategy in treating polyglutamine diseases.
Insights
Expanded polyglutamine proteins disrupt gene transcription by inhibiting cAMP-responsive element binding protein (CREB). Restoring CREB activity with cAMP or a histone deacetylase inhibitor reduces cell death, suggesting a therapeutic strategy for polyglutamine diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Mutant proteins with expanded polyglutamine stretches are implicated in neurodegenerative diseases.
- These proteins are hypothesized to cause transcriptional dysregulation through interactions with co-activators like TAFII130.
Purpose of the Study:
- To investigate the transcriptional activation of c-Fos and its suppression by expanded polyglutamine stretches.
- To explore potential therapeutic strategies targeting CREB-dependent transcriptional activation.
Main Methods:
- Neuro2a cells expressing expanded polyglutamine were used.
- Investigated the effects of cAMP, a histone deacetylase inhibitor (FR901228), and dominant-negative CREB vectors.
- Assessed CREB phosphorylation, c-Fos expression, and nuclear fragmentation.
Main Results:
- Expanded polyglutamine suppressed CREB phosphorylation and c-Fos induction in response to cAMP.
- Increased cAMP concentration or FR901228 treatment rescued these suppressions and reduced cytotoxicity.
- Dominant-negative CREB vectors diminished the protective effects of cAMP and FR901228.
Conclusions:
- Interference with CREB-dependent transcriptional activation by expanded polyglutamine contributes to neurodegeneration.
- Augmenting CREB activity is a promising therapeutic approach for polyglutamine diseases.
More Related Videos
06:49Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
Related Concept Videos
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Cooperative Binding of Transcription Regulators
Cis-regulatory Sequences